Bank of America’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-741,591
Closed -$25.9M 8606
2024
Q1
$25.9M Buy
741,591
+48,611
+7% +$1.77M ﹤0.01% 2027
2023
Q4
$26.3M Buy
692,980
+577,231
+499% +$12.4M ﹤0.01% 1882
2023
Q3
$2.12M Buy
115,749
+12,906
+13% +$270K ﹤0.01% 4195
2023
Q2
$2.67M Sell
102,843
-83,898
-45% -$1.96M ﹤0.01% 3955
2023
Q1
$3.52M Buy
186,741
+40,274
+27% +$937K ﹤0.01% 3851
2022
Q4
$3.61M Buy
146,467
+18,577
+15% +$546K ﹤0.01% 3714
2022
Q3
$2.3M Buy
127,890
+116,255
+999% +$2.1M ﹤0.01% 4141
2022
Q2
$132K Sell
11,635
-46,733
-80% -$688K ﹤0.01% 6338
2022
Q1
$1.3M Buy
58,368
+11,977
+26% +$306K ﹤0.01% 4985
2021
Q4
$2.03M Buy
46,391
+27,089
+140% +$1.08M ﹤0.01% 4544
2021
Q3
$643K Buy
19,302
+11,510
+148% +$350K ﹤0.01% 5444
2021
Q2
$214K Buy
7,792
+401
+5% +$8.35K ﹤0.01% 6057
2021
Q1
$148K Buy
7,391
+4,608
+166% +$135K ﹤0.01% 6229
2020
Q4
$92K Sell
2,783
-4,889
-64% -$130K ﹤0.01% 6033
2020
Q3
$138K Buy
+7,672
New +$139K ﹤0.01% 5508

Other funds holding INBX

Bank of America's INBX Position: Q2 2024 in Review

Bank of America sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 741,591 shares — an estimated $25.9M sold.

Bank of America first reported a position in INBX in Q3 2020 and held it in 15 quarters. The position peaked at $26.3M in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • Bank of America reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Bank of America sold 741,591 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $25.9M.
  • Bank of America first reported a position in Inhibrx, Inc. Common Stock in Q3 2020 and held it in 15 quarters.
  • Bank of America's Inhibrx, Inc. Common Stock position peaked at $26.3M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Bank of America's 13F filing for Q2 2024, filed 14 Aug 2024.